https://orcid.org/0000-0002-5564-1767
References
- Benassai G, Desiato V, Benassai G, et al. Adrenocortical carcinoma: what the surgeon needs to know. Case report and literature review. Int J Surg. 2014;12:S22–S28.
- Langenhuijsen J, Birtle A, Klatte T, et al. Surgical management of adrenocortical carcinoma: impact of laparoscopic approach, lymphadenectomy, and surgical volume on outcomes – a systematic review and meta-analysis of the current literature. Eur Urol Focus. 2016;1(3):241–250.
- Fassnacht M, Dekkers OM, Else T, et al. European society of endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2018;179(4):G1–G46.
- Fassnacht M, Assie G, Baudin E, et al. Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:476–490.
- Mirallié E, Blanchard C, Caillard C, et al. Adrenocortical carcinoma: impact of surgical treatment. Ann Endocrinol. 2019;80(5-6):308–313.
- Gaujoux S, Weinandt M, Bonnet S, et al. Surgical treatment of adrenal carcinoma. J Visc Surg. 2017;154(5):335–343.
- Zini L, Porpiglia F, Fassnacht M. Contemporary management of adrenocortical carcinoma. Eur Urol. 2011;60(5):1055–1065.
- Porpiglia F, Miller BS, Manfredi M, et al. A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma. Horm Cancer. 2011;2(6):372–377.
- Margonis GA, Kim Y, Prescott JD, et al. Adrenocortical carcinoma: impact of surgical margin status on long-term outcomes. Ann Surg Oncol. 2016;23(1):134–141.
- Terzolo M, Angeli A, Fassnacht M, et al. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 2007;356(23):2372–2380.
- Fassnacht M, Terzolo M, Allolio B, et al. Combination chemotherapy in advanced adrenocortical carcinoma. N Engl J Med. 2012;366(23):2189–2197.
- Beuschlein F, Weigel J, Saeger W, et al. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J Clin Endocrinol Metab. 2015;100(3):841–849.
- Araujo-Castro M, Pascual-Corrales E, Molina-Cerrillo J, et al. Immunotherapy in adrenocortical carcinoma: predictors of response, efficacy, safety, and mechanisms of resistance. Biomedicines. 2021;9(3):304.